Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Djukanovic, T. Harrison, P. Monk, N. Thomson, S. Johnston, S. Holgate, D. Davies (Southampton, , London, United Kingdom). LATE-BREAKING ABSTRACT: The effects of interferon beta on cold-induced asthma exacerbations. Eur Respir J 2012; 40: Suppl. 56, 347

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Mepolizumab (anti-IL-5) reduces exacerbations in patients with refractory eosinophilic asthma Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012 LATE-BREAKING ABSTRACT: Nasal and bronchial levels of Th2 cytokines correlate during a virus induced asthma exacerbation Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016 LATE-BREAKING ABSTRACT: Association of airway bacterial load with inhaled corticosteroid dosage in stable COPD Source: Annual Congress 2012 - New insights in pneumology - ERS inter-Assemblies late-breaking abstracts Year: 2012 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Long-term effects of inhaled corticosteroids on sputum bacterial and viral loads in COPD patients Source: International Congress 2015 – Infection in COPD: different aspects of the host/pathogen balance Year: 2015 LATE-BREAKING ABSTRACT: Blood eosinophils (EOS) are a biomarker of COPD exacerbation reduction with inhaled corticosteroids (ICS): An across-trials model-based approach Source: International Congress 2016 – New and old therapies for chronic lung diseases Year: 2016 LATE-BREAKING ABSTRACT: Reslizumab in patients with late-onset asthma with elevated blood eosinophils Source: International Congress 2015 – Hot topics on airway diseases: new horizons in treatment Year: 2015 LATE-BREAKING ABSTRACT: The role of FcRn in the allergic airway inflammation Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 LATE-BREAKING ABSTRACT: Advantageous therapeutic effects of a GATA-3-specific DNAzyme in comparison to corticosteroid treatment in animal models of allergic airway inflammation Source: Annual Congress 2009 - Infections, immunity and inflammation Year: 2009 LATE-BREAKING ABSTRACT: beta-blockers are associated with a reduction in COPD exacerbations in COPDGene Source: International Congress 2014 – COPD exacerbations Year: 2014 LATE-BREAKING ABSTRACT: Effect of inhalation of tobramycin on reduction of hospitalisation rate in severe COPD Source: Annual Congress 2012 - Pharmacological and non-pharmacological management of COPD Year: 2012 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: On the effectiveness of steroids in acute lung injury: Experimental separation between inflammation and hypoxemia Source: Annual Congress 2012 - Novel mechanisms of acute lung injury Year: 2012 LATE-BREAKING ABSTRACT: Predictive factors of frequent exacerbations in mild grade COPD patients Source: International Congress 2016 – Managing multimorbidity and lifestyle change in primary care Year: 2016 LATE-BREAKING ABSTRACT: CAT for evaluation of recovery after severe exacerbation of COPD Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 LATE-BREAKING ABSTRACT: Developing obstructive change over time is dominant in small airways in severe asthma Source: Annual Congress 2012 - Late breaking results: Asthma from phenotyping to emerging new treatments Year: 2012 LATE-BREAKING ABSTRACT: Novel inhaled ROR/c inhibitor for potential treatment of COPD Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Biomarkres in exacerbations of chronic obstructive pulmonary disease (ECOPD) Source: International Congress 2016 – In-patient and out-patient COPD management Year: 2016 COPD exacerbations: is eosinophilia a protective factor? Source: International Congress 2019 – Airway diseases and blood cells Year: 2019